Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
New findings in cancer vaccines described
November 18th, 2005
Data on cancer vaccines are outlined in reports from the United States, Germany and Switzerland. Study 1: New monoclonal antibodies to mesothelin are useful for immunohistochemistry, fluorescence-activated cell sorting, Western blotting, and ELISA. According to a study from the United States, "Mesothelin is a cell surface protein that is highly expressed in some malignant tumors, and is a promising target for immunotherapy. Recent data suggests that mesothelin is an adhesive protein and may have a role in the metastases of ovarian cancer. Although a few monoclonal antibodies (MAb) to mesothelin have been produced, they have limitations for the study...
Source: Drug Week (2005-11-18)
|
